1. Hou, Qinghua, Zhong, Yanfeng, Liao, Mengying, Li, Xiaoqing, Liu, Jixian. 2024. Upregulation of the tumor suppressor gene LIN9 enhances tumorigenesis and predicts poor prognosis of lung adenocarcinoma. In Heliyon, 10, e35012. doi:10.1016/j.heliyon.2024.e35012. https://pubmed.ncbi.nlm.nih.gov/39157309/
2. Esterlechner, Jasmina, Reichert, Nina, Iltzsche, Fabian, Finkernagel, Florian, Gaubatz, Stefan. 2013. LIN9, a subunit of the DREAM complex, regulates mitotic gene expression and proliferation of embryonic stem cells. In PloS one, 8, e62882. doi:10.1371/journal.pone.0062882. https://pubmed.ncbi.nlm.nih.gov/23667535/
3. Lai, Hongna, Wang, Rui, Li, Shunying, Li, Yudong, Liu, Yujie. 2019. LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP. In Science China. Life sciences, 63, 419-428. doi:10.1007/s11427-019-9581-8. https://pubmed.ncbi.nlm.nih.gov/31420851/
4. Reichert, Nina, Wurster, Sebastian, Ulrich, Tanja, Rapp, Ulf, Gaubatz, Stefan. 2010. Lin9, a subunit of the mammalian DREAM complex, is essential for embryonic development, for survival of adult mice, and for tumor suppression. In Molecular and cellular biology, 30, 2896-908. doi:10.1128/MCB.00028-10. https://pubmed.ncbi.nlm.nih.gov/20404087/
5. Roberts, Melyssa S, Sahni, Jennifer M, Schrock, Morgan S, Summers, Matthew K, Keri, Ruth A. 2020. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance. In Cancer research, 80, 1693-1706. doi:10.1158/0008-5472.CAN-19-3466. https://pubmed.ncbi.nlm.nih.gov/32054769/
6. Katsushima, Keisuke, Joshi, Kandarp, Yuan, Menglang, Eberhart, Charles G, Perera, Ranjan J. 2024. A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma. In Cell reports, 43, 113938. doi:10.1016/j.celrep.2024.113938. https://pubmed.ncbi.nlm.nih.gov/38460130/
智鼠故事 
